<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>According to current scientific investigations radiofrequency ablation (RFA) as a local ablative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> therapy for unresectable liver <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> is currently accepted as the best therapeutic choice </plain></SENT>
<SENT sid="1" pm="."><plain>The results of randomized trials justify RFA for small <z:hpo ids='HP_0001402'>hepatocellular carcinomas</z:hpo> (<z:mp ids='MP_0003331'>HCC</z:mp>) and RFA is considered to be a viable alternative to resection for inoperable patients with limited hepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e>, especially from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> LM) </plain></SENT>
<SENT sid="2" pm="."><plain>However, surgical resection still remains the gold standard for resectable <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> LM </plain></SENT>
<SENT sid="3" pm="."><plain>The intraprocedural image guidance modality of choice is computed tomography (CT) alongside CT fluoroscopy </plain></SENT>
<SENT sid="4" pm="."><plain>Contrast-enhanced ultrasound (CEUS) and magnetic resonance imaging (MRI) are used for preprocedural lesion detection and differentiation as well as for follow-up and can be used to perform RFA procedures as well </plain></SENT>
<SENT sid="5" pm="."><plain>This article highlights new developments in RFA </plain></SENT>
</text></document>